Table 1.
Demographic characteristics of enrolled subjects.
| Study Demographicsa | ||||
|---|---|---|---|---|
| All Patients (n=167) |
Diabetics (n=53) |
Non- Diabetics (n=114) |
p-valueb | |
| Age, years | 45.1 (13.8) | 51.1 (12.7) | 42.4 (13.4) | <0.01 |
| Female gender | 131 (78.4%) | 36 (67.9%) | 95 (83.3%) | 0.02 |
| BMI | 28.1 (6.9) | 31.0 (6.3) | 26.8 (6.7) | <0.01 |
| Caucasian race | 144 (87.3%) | 43 (82.7%) | 101 (89.4%) | 0.23 |
| Diabetes Subtype Type 1 Type 2 |
18 (44.0%) 35 (66.0%) |
|||
| Duration of symptoms (years) | 6.0 (7.4) | 6.6 (7.9) | 5.8 (7.1) | 0.51 |
| GCSI Total Score at Baseline | 2.9 (1.0) | 2.5 (1.0) | 2.7 (1.0) | 0.23 |
| Active marijuana usec | 14 (8.4%) | 5 (9.4%) | 9 (7.9%) | 0.74 |
| Active opiate usec | 19 (11.4%) | 5 (9.4%) | 14 (12.3%) | 0.59 |
a
Mean (standard deviation) unless otherwise noted
b
p-values are comparing diabetic vs. non-diabetic subjects
c
Marijuana and opiate use were active at time of baseline visit but held at least 72 h prior to motility testing